Chen Baixing, Moriarty T Fintan, Steenackers Hans, Vles Georges F, Onsea Jolien, Vackier Thijs, Spriet Isabel, Lavigne Rob, Richards R Geoff, Metsemakers Willem-Jan
Department of Trauma Surgery, University Hospitals Leuven, Leuven, Belgium.
Department of Development and Regeneration, KU Leuven, Leuven, Belgium.
J Bone Jt Infect. 2024 Oct 31;9(5):249-260. doi: 10.5194/jbji-9-249-2024. eCollection 2024.
Orthopedic-device-related infections (ODRIs) are challenging clinical complications that are often exacerbated by antibiotic resistance and biofilm formation. This review explores the efficacy of naturally occurring antimicrobials - including agents sourced from bacteria, fungi, viruses, animals, plants and minerals - against pathogens common in ODRIs. The limitations of traditional antibiotic agents are presented, and innovative naturally occurring antimicrobials, such as bacteriophage therapy and antimicrobial peptides, are evaluated with respect to their interaction with conventional antibiotics and antibiofilm efficacy. The integration of these natural agents into clinical practice could revolutionize ODRI treatment strategies, offering effective alternatives to conventional antibiotics and mitigating resistance development. However, the translation of these compounds from research into the clinic may require the substantial investment of intellectual and financial resources.
骨科器械相关感染(ODRIs)是具有挑战性的临床并发症,常因抗生素耐药性和生物膜形成而加剧。本综述探讨了天然存在的抗菌剂——包括源自细菌、真菌、病毒、动物、植物和矿物质的制剂——对ODRIs中常见病原体的疗效。介绍了传统抗生素制剂的局限性,并评估了创新的天然抗菌剂,如噬菌体疗法和抗菌肽,它们与传统抗生素的相互作用以及抗生物膜疗效。将这些天然制剂整合到临床实践中可能会彻底改变ODRI的治疗策略,为传统抗生素提供有效的替代方案,并减轻耐药性的发展。然而,将这些化合物从研究转化为临床应用可能需要大量的智力和财力投入。